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Abstract
Channels of the major intrinsic protein (MIP) of the lens transport water, thus playing an important role in lens fiber cell
homeostasis. Calmodulin (CAM) interacts with MIP and possibly regulates MIP channel permeability. Protein glycation has
been implicated in lens opacification. We previously identified sites of glycation of MIP, which are in close proximity to the
putative CAM binding site. This study is aimed to show the effect of in vitro and in vivo glycation on CAM binding to MIP.
Our results show that MIP and MP20 are the major CAM binding proteins of the lens membrane. In vitro incubation of lens
membranes with 1 M glucose decreased CAM binding by 38% (P6 0.001). Similarly, there was a progressive decrease in
CAM binding to diabetic lens membranes compared to age-matched controls (up to 30% decrease, P6 0.01). Mutation of
K228 and K238 as well as a triple K mutation (K228N, K238N, K259N) of MIP resulted in a decrease in CAM binding.
Thus, post-translational protein modifications of MIP influence CAM binding. Since CAM is the ubiquitous Ca2 receptor,
decreases in CAM binding to the target protein will affect the Ca2-mediated cellular processes leading to lens opacification
in diabetic and aging lenses. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Major intrinsic protein (MIP), also known as
aquaporin 0 (AQP0), is expressed exclusively in
lens ¢ber cells, constituting about 60% of the total
membrane proteins [1]. Although the structure is not
yet determined, MIP has six membrane-spanning do-
mains, with both amino and carboxy termini located
in the cytoplasm [2]. Several immunochemical and
ultrastructural studies showed that MIP is organized
in tetrameric arrays located in specialized 11^13 nm
junctional domains, which, in fact, cover a large por-
tion of the ¢ber cell surface [3]. MIP is the founding
member of the growing MIP family of water channel
proteins, which are involved in the transport of water
and glycerol [4^8]. Mutations in MIP have been iden-
ti¢ed in Lop, CatFr and H¢ congenital cataract
mouse models [9^11]. In these mice, expression of
MIP is very low and the C-terminus is truncated,
suggesting that normal levels of MIP with an intact
C-terminus are essential for the maintenance of lens
clarity. Furthermore, MIP is the candidate gene in
familial autosomal dominant cataracts [12], and mis-
sense mutations in MIP were identi¢ed in polymor-
phic and lamellar cataracts [13].
Calmodulin (CAM), the ubiquitous intracellular
Ca2 receptor, modulates Ca2-regulated processes
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in the cell. In the lens, CAM was shown to be in-
volved in a variety of functions, including activation
of cAMP phosphodiesterase and regulation of ade-
nylate cyclase [14], regulation of Ca2-ATPase [15],
modulation of ¢ber cell gap junctions [16], and pas-
sive permeability [17]. CAM was shown to interact
with MIP [18,19] and modulate channel uncoupling
in reconstituted liposomes [16]. A putative CAM
binding site has been identi¢ed on the C-terminus
arm of MIP (residues 223^235) [20]. Recently, Caha-
lan and Hall [21] demonstrated that a Ca2-mediated
increase in water permeability of MIP is modulated
by CAM. Thus, CAM seems to have a regulatory
role in the function of MIP.
Glycation, a post-translational protein modi¢ca-
tion, is involved in a variety of age- and diabetes-
related complications, including cataracts. Our ear-
lier studies have shown that MIP undergoes glyc-
ation, which a¡ected CAM-mediated channel un-
coupling in reconstituted liposomes [22,23].
Furthermore, we identi¢ed K228, K238, and K259
as the in vitro sites of glycation [24]. CAM also
undergoes glycation, and in vitro glycation of
CAM resulted in a 54% decrease in its ability to
bind Ca2 [25]. It has been shown that in diabetic
rats, lens CAM is glycated resulting in reduced acti-
vation of phosphodiesterase [26]. This study has
three aims: ¢rst, to show the e¡ect of glycation of
MIP on CAM binding; second, to show the e¡ect of
in vitro glycation of CAM on this binding; and ¢-
nally, to con¢rm the role of lysine residues of MIP in
CAM binding. Some of the results here were previ-
ously presented in abstract form [27].
2. Materials and methods
2.1. Lenses
Calf eyes were obtained from a local abattoir,
lenses were enucleated, and membranes were pre-
pared as described below. One month old male
Sprague-Dawley rats were made diabetic with a sin-
gle i.v. injection of streptozotocin (55^65 mg/kg body
weight). A total of 100 rats were made diabetic and
another 30 animals served as controls. About 30^35
diabetic rats were killed 30, 60, and 90 days post
streptozotocin injection. On the 90th day, 30 age-
matched control rats were also killed. About 10^12
pairs of diabetic or control lenses were pooled and
membranes were prepared as described below.
2.2. Preparation of lens membranes
Calf or rat lens membranes were prepared as per
the method of Russell et al. [28]. Decapsulated lenses
were homogenized in ice-cold bu¡er A (5 mM Tris-
HCl, pH 8.5, 1 mM EDTA and 0.1 mM PMSF). The
soluble fraction was removed by centrifugation and
the pellet was successively washed with 7 M urea,
0.1 M NaOH containing 10 mM L-mercaptoethanol,
and bu¡er A, followed by sucrose gradient ultracen-
trifugation (65%, 45%, 25% and 8% sucrose gradient)
at 105 000Ug using an SW55 rotor. Membranes sedi-
mented at the 25^45% interface were collected and
washed with sterile PBS.
2.3. In vitro glycation of lens membranes
Calf lens membranes were incubated with 1 M
glucose in the presence of 0.12 M NaCNBH3, at
37‡C for 5 days. Following the incubation, the mem-
branes were washed with PBS and used for further
studies.
2.4. Estimation of levels of glycation
Level of glycation (Amadori products) was esti-
mated by phenyl boronate a⁄nity chromatography
[23]. Lens membranes were ¢rst solubilized in 1%
octyl glucoside and then applied to the column. Pro-
tein content in the unbound and bound fractions was
estimated and the level of glycation was expressed as
a percentage.
2.5. Site-directed mutagenesis
In order to generate lysine mutants, the sequences
coding for K228, K238 and K259 were mutated to N
by a single base change using a PCR based site-di-
rected mutagenesis protocol (QuickChange kit, Stra-
tagene). This protocol allows speci¢c mutations in
any double stranded plasmid. The MIP/pBlueBacIII
construct was used as the template with oligonucleo-
tide primers, as follows.
The K238N mutant was generated using: 5P-CTC
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TTC CCT CGG CTC AAC AGT GTT TCT GAG
AGAC-3P (sense); 5P-GTC TCT CAG AAA CAC
TGT TGA GCC GAG GGAAG-3P (antisense).
The K238N mutant was generated using: 5P-CTG
TCT ATT CTC AAC GGT TCC AGG-3P (sense);
5P-CTG GGC CTG GAA CCG TTG AGA ATAG-
3P (antisense). The K259N mutant was generated us-
ing: 5P-GGA ACC TGT TGA ACT GAA CAC
CCA GGC CCTG-3P (sense); 5P-CAG GGC CTG
GGT GTT CAG TTC AAC AGG TTCC-3P (anti-
sense). The triple K mutant (K228N, K238N,
K259N) was generated by sequentially mutating
each lysine residue.
2.6. Baculovirus expression of wild type and lysine
mutant MIP
The wild type and mutant MIP were expressed in
the baculovirus expression system as described earlier
[29]. Brie£y, the cDNA coding for wild type and
lysine mutant MIP were directionally cloned into
the pBlueBacIII shuttle vector and transferred to
AcMNPV baculovirus genome by homologous re-
combination. The resultant AcMNPV/MIP recombi-
nant was used to transfect sf9 insect cells.
The sf9 cells expressing MIP (wild type and lysine
mutant) were settled by gentle centrifugation at
500 rpm for 10 min. The cells were washed twice
with Tris-NaCl bu¡er (50 mM Tris, pH 8.4 contain-
ing 0.15 M NaCl, 1 mM KCl, 1 mM CaCl2, and
0.5 mM MgCl2), resuspended in bu¡er A (5 mM
Tris, pH 8.5, 1 mM EDTA, and 0.1 mM PMSF)
and lysed by sonication (probe type sonicator, 15 s
burstsU4). The lysate was centrifuged at 20 000Ug
for 15 min. Pelleted cell membranes were washed
extensively with bu¡er A and used in the calmodulin
binding studies as described elsewhere.
2.7. In vitro glycation of calmodulin
About 100 Wg of a⁄nity puri¢ed bovine brain
CAM (Calbiochem, La Jolla, CA) was incubated
with 0.35 M glucose at 37‡C for 5 days [25]. The
incubation medium also contained 1 mM CaCl2,
0.1% sodium azide, and PBS in a ¢nal volume of
0.4 ml. After the incubation, 5 ml of cold PBS was
added and the mixture was concentrated to 0.5 ml in
microconcentrators (3 kDa cuto¡, Amicon). The
glycated CAM was then iodinated with 125I as de-
scribed below.
2.8. Iodination of calmodulin
CAM was iodinated with 125I (Amersham Radio-
chemicals) by the lactoperoxidase method [30]. Iodi-
nated CAM was separated on a Sephadex G-25 col-
umn (Pharmacia Biotech) and used in direct binding
and gel overlay assays.
2.9. Calmodulin binding assay
Direct binding of CAM to the lens membranes was
done according to the procedure described by Graf et
al. [30]. Brie£y, the assay mixture contained 1 mg of
bovine serum albumin (BSA), 6 mM MgCl2, 0.8 mM
CaCl2, 100 mM NaCl, 20 mM KCl, 0.5 mM EGTA,
25 mM Tris-HCl bu¡er, pH 7.4, and 0.5 mg lens
membranes. To this mixture, 125I-CAM was added
and incubated for 30 min at 37‡C. Binding was
stopped by the addition of ice-cold Tris-HCl bu¡er
and centrifuged in a microfuge at 15 000Ug for
20 min at 4‡C. The pellet was washed three times
and resuspended in Tris-HCl bu¡er and an aliquot
was counted in a Q counter.
A binding curve was generated with normal calf
lens membranes and di¡erent amounts (5^250 ng) of
125I-CAM. Competitive binding assays were done
identically with variable amounts (0^100 ng) of un-
labeled calmodulin and a constant amount (125 ng)
of 125I-CAM.
2.10. Gel overlay assay
CAM binding to MIP was determined by the gel
overlay assay described by Louis et al. [18,19].
Brie£y, lens membranes or sf9 cell membranes (ex-
pressing wild type or lysine mutant MIP) were frac-
tionated on 12% SDS-PAGE (0.75 mm thick), ¢xed
for 3 h (three changes) in 25% isopropanol and 10%
acetic acid mixture, washed for 1 h (three changes) in
gel overlay bu¡er (50 mM Tris-HCl, pH 7.6, 0.2 M
NaCl, and 1 mM CaCl2), blocked with 1% BSA for
2 h, and incubated overnight with 125I-CAM (ap-
prox. 3U106 cpm) in gel overlay bu¡er. Gels were
then washed thoroughly for 3 h in gel overlay bu¡er,
dried, and processed for autoradiography.
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3. Results
3.1. In vitro and in vivo glycation of lens membrane
proteins
The level of glycation (Amadori products) was es-
timated by phenyl boronate a⁄nity chromatography.
In vitro incubation of bovine lens membranes with
1 M glucose for 5 days resulted in a 5-fold increase
of early glycation compared to control incubations
(P6 0.001) (Fig. 1A). There was a gradual increase
in the level of glycation of diabetic rat lens mem-
branes, reaching an about 2-fold higher level on the
90th day post streptozotocin injection compared to
non-diabetic controls. These increases were statisti-
cally signi¢cant (P6 0.05 on the 30th day and
P6 0.001 on the 60th and 90th days, when compared
with non-diabetic controls) (Fig. 1B).
3.2. Binding of 125I-calmodulin to lens membranes
In order to show the speci¢city of 125I-CAM bind-
ing to lens membranes, concentration and competi-
tive inhibition curves were generated with normal
calf lens membranes. We observed a concentration
dependent increase in the binding of 125I-CAM to
Fig. 1. In vitro and in vivo glycation of MIP. (A) Calf lens membranes were incubated without (Control) and with 1 M glucose for
5 days, then washed and solubilized. Levels of glycation of MIP were estimated by phenyl boronate a⁄nity chromatography. (B) Lens
membranes were isolated on days 30, 60 and 90 of streptozotocin-induced diabetic rat lenses along with controls (C). MIP glycation
was estimated as above. *P6 0.05; **P6 0.001 when compared with respective controls.
Fig. 2. Speci¢city of CAM binding. (A) Increasing amounts (5^250 ng) of 125I-CAM were added to lens membranes to show a linear
increase in CAM binding to lens membrane proteins. (B) A competitive inhibition assay was done using 125 ng of 125I-CAM and
varying amounts of unlabeled CAM (0^100 ng) to show the speci¢city of CAM binding.
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lens membranes (Fig. 2A). When increasing amounts
of unlabeled CAM was added as a competitor a lin-
ear decrease of 125I-CAM binding was seen (Fig. 2B).
There was a 60% decrease in the radioactivity incor-
poration when 100 ng of unlabeled CAM was used
as the competitor for 125 ng of 125I-CAM (Fig.
2B).
In order to show the e¡ect of in vitro glycation,
bovine lens membranes incubated with and without
glucose were used in the binding assays. There was a
38% (P6 0.01) decrease in 125I-CAM binding to the
in vitro glycated calf lens membranes compared to
Fig. 3. E¡ect of in vitro and in vivo glycation, and role of lysine residues on CAM binding to MIP. (A) Calf lens membranes were
glycated in vitro and then used in the CAM binding studies. (B) Lens membranes from days 30, 60 and 90 of streptozotocin-induced
diabetic rats along with controls were used in the CAM binding studies. (C) Wild type and lysine mutants, K228N, K238N, K259N,
and the triple K mutant, were expressed in the baculovirus expression system and then used in CAM binding studies. *P6 0.05;
**P6 0.01 compared to respective controls or wild type.
Fig. 4. E¡ect of diabetes on CAM binding to MIP: gel overlay
assay. Control (lane 1) and 90th day diabetic (lane 2) rat lens
membranes were resolved on SDS-PAGE and used in the gel
overlay assay. (A) Coomassie blue stained gel and (B) autora-
diogram of the gel overlay assay.
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control incubations (Fig. 3A). Similarly, there was a
progressive decrease in the binding of calmodulin to
diabetic rat lens membranes. The decrease was about
11%, 23% and 30% on day 30, 60 and 90 diabetic
rats, respectively, when compared to non-diabetic
controls (Fig. 3B).
To identify the CAM binding proteins in lens
membranes, control and 90th day diabetic rat lens
membrane proteins were resolved on SDS-PAGE
and the gel overlay assay was performed. As ex-
pected, we found that in diabetic lenses, MIP is par-
tially cleaved to 24 kDa and 22 kDa proteins (Fig.
4A). Possibly MP20 also degraded to lower molecu-
lar mass products (not resolved on the gel). In agree-
ment with earlier reports [18,19], our gel overlay as-
say shows that MIP and MP20 are the major CAM
binding proteins in lens membranes (Fig. 4B). As
expected, there was a signi¢cant decrease in CAM
binding to MIP in 90th day diabetic lenses compared
to controls (compare lane 2 with lane 1, Fig. 4B). No
binding to MP20 was observed in diabetic lenses
(compare lane 2 to 1, Fig. 4B). Interestingly, CAM
did not bind to the degradation products of MIP (24
kDa or 22 kDa peptides) either in control or diabetic
lenses (Fig. 4B).
3.3. Studies with lysine mutant MIP
Since lysine residues are the major glycation sites,
each of the three lysine residues were replaced with
asparagine residues by site-directed mutagenesis. The
resultant K228N, K238N, K259N, and triple K mu-
tant (K228N, K238N, and K259N) were expressed in
the baculovirus expression system and the e¡ect of
these lysine mutations on CAM binding was studied.
For direct binding assay, the insect cell membranes
expressing either wild type MIP or lysine mutant
MIP were used. As shown in Fig. 3C, K228N,
K238N and triple lysine mutations resulted in a sig-
ni¢cant decrease in CAM binding compared to wild
type (P6 0.01). However, the K259N mutation
seems to have no e¡ect on CAM binding. Further-
more, the e¡ect of lysine mutations on CAM binding
was also analyzed by the gel overlay assay (Fig. 5).
Wild type and mutant MIP were ¢rst puri¢ed by gel
permeation HPLC as described earlier [29] and then
subjected to the gel overlay assay to measure CAM
binding. The intensity of the stained gels and corre-
sponding autoradiograms were determined by densi-
tometry. The ratio obtained for wild type was taken
as 100% and compared with di¡erent mutants. The
ratios for lysine mutations were 89 þ 5% for K228N,
86 þ 11% for K238N, 103 þ 7% for K259N and
51 þ 6% for triple lysine mutant. In agreement with
the direct binding assay, the gel overlay assay also
showed a 49% decrease in CAM binding to the triple
lysine mutant (Fig. 5B, lane 5). K228N and K238N
lysine mutations showed some decrease in CAM
binding, and K259N had no e¡ect on CAM binding
(Fig. 5B).
Fig. 5. Role of lysine residues on CAM binding in the gel over-
lay assay. (A) Coomassie blue stained gel and (B) autoradio-
gram of the gel overlay assay. Wild type and lysine mutant
MIPs were expressed in the baculovirus expression system, puri-
¢ed by HPLC, and then used in the gel overlay assay. Varying
degrees of reduction in CAM binding were seen with the indi-
vidual lysine mutants. However, the triple K mutant showed a
substantial reduction in binding.
Fig. 6. E¡ect of CAM glycation on binding. (A) Coomassie
blue stained gel and (B) autoradiogram of the overlay assay.
CAM was glycated in vitro, iodinated, and used in the gel over-
lay assay. Lens membranes from control (lane 1) and 90th day
diabetic (lane 2) lenses were used in this assay. Note that glyc-
ated CAM failed to bind to MIP obtained either from control
or diabetic lenses.
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3.4. E¡ect of glycation of calmodulin on the binding
Since CAM itself is also a target for glycation [25],
CAM was ¢rst glycated in vitro, iodinated, and used
in the gel overlay assay. While non-glycated CAM
readily bound to MIP and MP20 (see Fig. 4), the
glycated CAM failed to bind to normal or diabetic
rat lens membranes (Fig. 6B).
4. Discussion
This study shows that CAM binding to MIP is
decreased in diabetic lenses. Glycation and glyc-
ation-induced protein conformational changes seem
to play an important role in the interaction of CAM
with the binding site on MIP. These results also dem-
onstrate that lysine residues at the putative CAM
binding site on MIP play an important role in this
binding. Since CAM is a ubiquitous Ca2 binding
protein, decreased CAM binding to MIP is likely
to a¡ect Ca2-mediated cellular processes, including
water permeability, and thus a¡ecting lens ¢ber cell
homeostasis.
MIP is the major CAM binding protein in lens
¢ber cell membranes. Earlier studies have shown
CAM-mediated channel uncoupling in reconstituted
liposomes [16]. Glycation of MIP resulted in only
partial uncoupling by CAM [22]. As shown in Fig.
3A, in vitro glycation decreased CAM binding to
MIP. Thus it appears that the partial uncoupling
seen in our earlier studies [22] may in fact be due
to decreased binding of CAM to glycated MIP.
How does glycation in£uence CAM binding? The
putative CAM binding site on MIP has been identi-
¢ed as residues 223^235 [20], and Lys228 and Lys238
are two of the ¢ve basic residues at this binding site.
Earlier, we identi¢ed Lys228, Lys238, and Lys259 as
the in vitro glycation sites in MIP [23]. It is expected
that glycation of Lys228 and Lys238 would decrease
the net positive charge at the CAM binding domain,
which would a¡ect the binding. Additionally, protein
conformational changes brought about by glycation
may also in£uence CAM binding. To understand the
role of lysine residues in CAM binding we carried
out binding studies using lysine mutant MIPs. As
shown in Fig. 3C, there was an about 30^40% de-
crease in CAM binding to K228N, K238N and triple
lysine mutants compared to wild type. As expected,
the K259N mutation seems to have no e¡ect on
CAM binding (Fig. 3C). It is expected that deletion
of three positively charged residues would bring
about not only signi¢cant charge di¡erences but
also dramatic conformational changes compared to
the deletion of single positively charged residues.
Although the gel overlay assay con¢rmed a signi¢-
cant decrease in CAM binding to the triple lysine
mutant (Fig. 5B, lane 5), single lysine mutations
showed only a marginal change in CAM binding.
Thus it appears that there are some di¡erences in
accessibility of the binding site to CAM. In the direct
binding assay, the MIP is embedded in the lipid bi-
layer possibly in tetrameric con¢guration, whereas in
the gel overlay assay the proteins are dissociated
from their membrane components making the acces-
sibility of the binding site relatively easier. Taken
together these analyses show that lysine residues,
particularly at the binding site, play an important
role in the binding of CAM to MIP.
In diabetic lenses, we observed a progressive in-
crease in MIP glycation (Fig. 1B) along with a par-
allel decrease in CAM binding (Figs. 2B and 4),
which con¢rms our in vitro results. The gel overlay
assay showed degradation of MIP to 22 kDa and
24 kDa products in diabetic lenses, and CAM did
not bind to these degraded products (Fig. 4), suggest-
ing that intact MIP is needed for CAM binding. Our
recent mass spectrometric analysis showed that K238
is one of the major truncation sites in the diabetic
lenses (unpublished observations). Based on these
observations, it is concluded that charge di¡erences
and/or protein conformational changes and trunca-
tion in£uence CAM binding to MIP.
Earlier studies showed that CAM is also the target
of glycation, which a¡ects Ca2 binding [25]. In ad-
dition, it was shown that CAM is glycated in diabetic
rat lenses [26]. The data presented in Fig. 6 show that
in vitro glycated CAM bound neither to normal MIP
from controls rats nor to the glycated MIP from
diabetic rats. It is interesting to note that there was
only a 40% decrease in CAM binding when MIP is
glycated, whereas glycation of CAM resulted in
100% loss of binding. The rate of glycation of mem-
brane integral proteins, like MIP, could be far lower
than that of soluble cytosolic proteins such as CAM.
We estimated the level of glycation by phenyl boro-
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nate a⁄nity chromatography, and glycation of CAM
was 4-fold higher than that of MIP under the exper-
imental conditions used in this study (data not
shown). Furthermore, the e¡ect of glycation on these
proteins seems to be di¡erent. Glycation of CAM
signi¢cantly reduces its Ca2 binding capacity and
possibly Ca2-mediated conformational changes are
needed for the binding to the target site. This may
explain the di¡erential response of these two proteins
as a result of glycation. Furthermore, it is expected
that glycation of CAM and glycation of the CAM
binding site on MIP will have a synergistic e¡ect on
the CAM-MIP interaction.
In the avascular lens, MIP channels provide the
network of channels for the passage of nutrients
and antioxidants and the removal of metabolic waste
products. Recent studies have unequivocally demon-
strated that MIP channels transport water and glyc-
erol [5^8], thus playing an important role in lens ¢ber
cell homeostasis. Cahalan and Hall [21] have ele-
gantly demonstrated the regulation of MIP water
permeability by Ca2, which is modulated by
CAM. However, there are di¡erences between their
study and ours. Using an oocyte expression system,
Cahalan and Hall [21] showed that CAM inhibitors
increased MIP water permeability by 3.7-fold, thus
shifting from a low to high permeability mode of
MIP water permeability. However, our results show
a decreased binding of CAM to MIP in diabetic
lenses (Figs. 3 and 4), which is associated with de-
creased water permeability [31]. These apparent dif-
ferences may be explained by the fact that our stud-
ies used normal MIP under pathological conditions
(diabetes), whereas Cahalan and Hall [21] used a
heterologous expression system under in vitro condi-
tions.
In conclusion, this study shows that post-transla-
tional protein modi¢cations in£uence CAM binding
to the MIP target protein, a¡ecting Ca2-mediated
cellular processes. Since MIP is involved in water
transport of the lens, decreased CAM binding may
a¡ect the CAM-mediated modulation of MIP chan-
nels, resulting in lens opaci¢cation.
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